|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 355.25 USD | -1.44% |
|
-3.49% | +8.54% |
| 13/07 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
| 13/07 | UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -1.44% | -3.49% | +8.54% | +19.60% | +45.18% | 19TCr |  |  | |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
